Amphastar Pharmaceuticals, Inc. (AMPH) › Operating Cash FlowAmphastar Pharmaceuticals, Inc. (AMPH) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2015: $10.68M2016: $38.56M2017: $39.21M2018: $38.19M2019: $41.76M2020: $57.27M2021: $97.99M2022: $89.18M2023: $183.50M2024: $213.39M2025: $156.12M$156.12M2015Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$156.12M-26.8%2024$213.39M+16.3%2023$183.50M+105.8%2022$89.18M-9.0%2021$97.99M+71.1%2020$57.27M+37.1%2019$41.76M+9.4%2018$38.19M-2.6%2017$39.21M+1.7%2016$38.56M+261.0%2015$10.68M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share